4 fr angiographic catheter (Merit Medical)
86
Structured Review
Merit Medical
4 fr angiographic catheter
4 Fr Angiographic Catheter, supplied by Merit Medical, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/4+fr+angiographic+catheter/147+angiographic+bernstein+catheter/pm41682942-67-13-17
Average 86 stars, based on 1 article reviews
4 Fr Angiographic Catheter, supplied by Merit Medical, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/4+fr+angiographic+catheter/147+angiographic+bernstein+catheter/pm41682942-67-13-17
Average 86 stars, based on 1 article reviews
4 fr angiographic catheter - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
other:Article Title: Endovascular Management of Iliac Hematoma Associated with May-Thurner Syndrome Using Mechanical Thrombectomy and Bare-Metal Stenting: A Case Report. Article Snippet: A 0.035-inch, 260-cm hydrophilic guidewire (Terumo, Tokyo, Japan) was carefully negotiated with a Article Title: Endovascular Management of Iliac Hematoma Associated with May–Thurner Syndrome Using Mechanical Thrombectomy and Bare-Metal Stenting: A Case Report Article Snippet: A 0.035-inch, 260-cm hydrophilic guidewire (Terumo, Tokyo, Japan) was carefully negotiated with a Article Title: Percutaneous transhepatic cholangioscopy for benign and malignant biliary disease using a novel short single-operator cholangioscope. Article Snippet: Background The length of conventional single-use cholangioscopes poses a challenge for percutaneous or laparoscopic approaches for direct visualization of the biliary tract.. The aim of this retrospective observational clinical study was to assess the use of a dedicated percutaneous short single-operator cholangioscope (PSSOC) for diagnosis and treatment of benign or malignant biliary diseases.. Methods Retrospective analysis of a prospectively maintained database including all consecutive patients undergoing percutaneous transhepatic cholangioscopy with the PSSOC between 06/2021 and 01/2023. |
